在患有血友病A的儿科患者中严重出血 接受埃米齐祖马布预防治疗
Jessica Garcia1,2, Matthew R Hammer3,2, Ayesha Zia1,2
1Division of Hematology/Oncology, Department of Pediatrics, UT Southwestern Medical Center, Dallas, Texas, USA.
Research and practice in thrombosis and haemostasis
|December 6, 2023
概括
在患有血友病A的儿科患者中,尽管使用埃米齐祖马布,但仍可能发生严重出血. 这些真实数据表明,仔细监测和治疗调整对于管理该群体出血事件至关重要.
科学领域:
- 儿科血液学 儿科血液学
- 血友病 一种治疗方法
- 药物监督 药物监督 药物监督
背景情况:
- 在临床试验中,埃米齐祖马布在预防A型血友病的出血方面表现有前途.
- 关于埃米齐祖马布在预防小儿血友病A患者严重出血的有效性,现实世界的数据有限.
研究的目的:
- 评估埃米齐祖马布在预防A型血友病儿科患者严重出血方面的实际有效性.
主要方法:
- 在37名儿科男性 (≤18岁) 接受埃米齐祖马布预防的回顾性图表审查.
- 平均随访时间为30.5个月.
- 从德克萨斯州达拉斯的儿童医疗中心收集的数据.
主要成果:
- 四名患有严重血友病A的儿科患者经历了严重的出血 (引起或未引起),需要住院治疗.
- 患者患有含有或不含抑制剂的血友病A.
结论:
- 严重的出血可能发生在儿科重度血友病A患者治疗埃米齐祖马布.
- 临床医生应为患者提供风险建议,并考虑治疗调整 (例如,艾米齐祖马布定位,XVIII因子) 以控制低于最佳的出血或高风险活动.
相关概念视频
Disorders of Hemostasis
926
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
926
Epistaxis
171
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
171
Anticoagulant Drugs: Low-Molecular-Weight Heparins
711
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
711
Introduction to Hemostasis
8.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.0K
Esophageal Varices-II: Clinical Features and Management
72
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
72
Extrinsic and Intrinsic Pathways of Hemostasis
7.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.9K


